LifeStance Health Group, Inc.

LifeStance Health Group, Inc.

LFSTNYSE / NASDAQHealthcareSmall cap

$13.82+$0.48 (+3.6%)

Last close · Data as of Nov 20, 2026

Market cap
$2.9B
P/E
301.9x
EV / EBITDA
39.9x
Revenue
$1.4B
Net margin
0.7%
ROCE
1.2%

+123.6% over the last year

LifeStance Health Group, Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
+13.1%
3M
+9.2%
6M
+79.9%
1Y
+123.6%
5Y
+59.8%

52-week range

Day change +$0.48 (+3.6%) from $13.34 to $13.82 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in LFST, bought on each weekday since 2021.

News & filings

What LifeStance Health Group filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

StrengthEBITDA grew 97.6% in fiscal 2025, 83.7 points more than revenue.

Concerns (1)

  • Return on equity of 0.6%.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

Read moreShow less

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Sector
Healthcare
Shares outstanding
322.1M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$2.9B
P/E
301.9x
P/B
1.9x
EV / EBITDA
39.9x
EV / Sales
2.2x
P/S
2.0x
52-week high
$14.60
52-week low
$6.18

Profitability

Operating margin
1.7%
Net margin
0.7%
EBITDA margin
5.5%
ROE
0.6%
ROCE
1.2%
ROIC
1.1%
ROA
0.4%
Asset turnover
0.65

Growth

Revenue
$1.4B
Revenue growth, 1Y
13.9%
Revenue CAGR, 3Y
18.3%
Net profit growth, 1Y
-116.8%
Free cash flow
$110.0M

Solvency

Current ratio
1.65
Debt / Equity
0.31
Debt / Assets
0.22
CFO / Net profit
15.12
Cash / Market cap
8.5%

Where the revenue went

Of every $100 of FY2025 revenue, $1 was left as net income.

LifeStance Health Group, Inc. income statement flow, FY2025
LifeStance Health Group, Inc. income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$963.2M
RevenueGross profit$461.1M
Gross profitSelling, general and administrative$382.2M
Gross profitOther operating expenses$54.7M
Gross profitOperating income$24.1M
Operating incomePretax income$12.4M
Operating incomeInterest and other expense$11.8M
Pretax incomeTax and other$2.7M
Pretax incomeNet income$9.7M

Revenue and net profit

Revenue grew 13.9% in FY2025; net profit is the dashed line.

LifeStance Health Group, Inc. revenue and net profit by fiscal year
LifeStance Health Group, Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$859.5M-$215.6M
FY2023$1.1B-$186.3M
FY2024$1.3B-$57.4M
FY2025$1.4B$9.7M

Cash flows

FY2025: $146.2M from operations, $110.0M free after investment (dashed).

LifeStance Health Group, Inc. operating and free cash flow by fiscal year
LifeStance Health Group, Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$52.8M-$26.5M
FY2023-$16.9M-$57.4M
FY2024$107.3M$85.7M
FY2025$146.2M$110.0M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$1.4B+13.9%1Y
EBITDA
$78.8M+97.6%1Y
Net profit
$9.7M
Cash from operations
$146.2M+36.3%1Y
Free cash flow
$110.0M+28.4%1Y
Revenue CAGR, 3Y
18.3%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$1.4B$78.8M$9.7M$110.0M0.6%+13.9%-116.8%

Monthly returns

Month-by-month returns of LFST across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$2.2B
Liabilities$682.9M
Equity$1.5B
Paid-in capital$2.3B
Retained earnings-$808.6M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; LFST highlighted.

P/E against peers

LFST trades at 301.9x earnings against a peer median of -6.9x.

  1. LifeStance Health Group, Inc. (this company)301.9x

Not shown (no positive earnings and no EV / Sales): Dyne Therapeutics, Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
LifeStance Health Group, Inc.LFSTthis company$2.9B301.9x1.9x0.6%39.9x
Alignment Healthcare, Inc.ALHC$3.1B—17.4x-0.4%62.7x
Dyne Therapeutics, Inc.DYN$3.0B-6.8x3.1x-45.9%-5.3x
Warby Parker Inc.WRBY$3.0B1803.7x8.0x0.4%64.7x
Adaptive Biotechnologies CorporationADPT$2.9B—13.2x-27.2%—
GRAIL, Inc.GRAL$2.9B-7.0x1.1x-15.8%-7.0x
Brookdale Senior Living Inc.BKD$2.8B-10.8x-63.4x587.0%23.5x
Soleno Therapeutics, Inc.SLNO$2.8B132.3x6.1x4.6%96.7x
Arcutis Biotherapeutics, Inc.ARQT$2.7B-170.1x14.5x-8.5%1582.5x
Peer median—-6.9x7.1x-4.5%62.7x

Year-to-date ROI

LFST since 1 January, against earlier years.

Historical volatility

LFST's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

LifeStance Health Group, Inc. operating margin by fiscal year
LifeStance Health Group, Inc. operating margin by fiscal year
DateOperating margin
FY2022-24.5%
FY2023-17.9%
FY2024-2.5%
FY20251.7%
LineFY2025
Cost of revenueCost Of Revenue$963.2M
Gross profitGross Profit$461.1M
Operating expensesOperating Expense$436.9M
Depreciation and amortisationDepreciation And Amortization In Income Statement$54.8M
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$54.8M
Total expensesTotal Expenses$1.4B
Pretax incomePretax Income$12.4M

Learn while you research

Academy chapters picked for LifeStance Health Group, Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Valuation Multiples ExplainedThis stock trades at a P/E of 301.9, learn when high multiples are justified.6 min read
  3. 03 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  4. 04 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  5. 05 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  6. 06 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →